McLaughlin Gerald W. 4
4 · Neos Therapeutics, Inc. · Filed Mar 4, 2019
Insider Transaction Report
Form 4
McLaughlin Gerald W.
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-03-01+523,583→ 523,583 totalExercise: $2.31Exp: 2029-03-01→ Common Stock (523,583 underlying)
Footnotes (1)
- [F1]This stock option will vest in four equal, annual installments beginning on March 1, 2019.